Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) have earned a consensus rating of “Buy” from the twenty-two analysts that are covering the stock. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $93.45.

Several analysts have recently commented on the company. Evercore ISI reiterated a “buy” rating and set a $93.00 price objective on shares of Walgreens Boots Alliance in a report on Thursday, July 7th. JPMorgan Chase & Co. reiterated a “buy” rating on shares of Walgreens Boots Alliance in a report on Thursday, July 7th. Barclays PLC increased their price objective on Walgreens Boots Alliance from $76.00 to $79.00 and gave the company an “equal weight” rating in a report on Thursday, July 7th. Robert W. Baird reiterated an “outperform” rating and set a $98.00 price objective on shares of Walgreens Boots Alliance in a report on Monday, June 27th. Finally, Deutsche Bank AG reiterated a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 18th.

Walgreens Boots Alliance (NASDAQ:WBA) traded up 0.44% during mid-day trading on Wednesday, reaching $78.42. The company’s stock had a trading volume of 1,681,587 shares. Walgreens Boots Alliance has a one year low of $71.50 and a one year high of $95.74. The company has a market capitalization of $84.88 billion, a price-to-earnings ratio of 27.10 and a beta of 1.01. The stock has a 50-day moving average price of $81.09 and a 200-day moving average price of $81.12.

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 12th. Investors of record on Friday, August 19th were issued a $0.375 dividend. This represents a $1.50 annualized dividend and a yield of 1.92%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.36. The ex-dividend date of this dividend was Wednesday, August 17th. Walgreens Boots Alliance’s payout ratio is presently 51.90%.

In other news, Director William C. Foote sold 2,067 shares of the business’s stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $81.35, for a total transaction of $168,150.45. Following the transaction, the director now directly owns 26,690 shares in the company, valued at approximately $2,171,231.50. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Kathleen Wilson-Thompson sold 29,695 shares of the business’s stock in a transaction that occurred on Thursday, July 14th. The stock was sold at an average price of $83.00, for a total value of $2,464,685.00. The disclosure for this sale can be found here. 21.10% of the stock is owned by corporate insiders.

Hedge funds and other institutional investors have recently modified their holdings of the company. CapWealth Advisors LLC boosted its position in shares of Walgreens Boots Alliance by 30.0% in the first quarter. CapWealth Advisors LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $110,000 after buying an additional 300 shares in the last quarter. Kings Point Capital Management boosted its position in shares of Walgreens Boots Alliance by 12.8% in the first quarter. Kings Point Capital Management now owns 1,323 shares of the pharmacy operator’s stock valued at $111,000 after buying an additional 150 shares in the last quarter. Jolley Asset Management LLC boosted its position in shares of Walgreens Boots Alliance by 104.5% in the second quarter. Jolley Asset Management LLC now owns 1,370 shares of the pharmacy operator’s stock valued at $114,000 after buying an additional 700 shares in the last quarter. Westbourne Investment Advisors Inc. bought a new position in shares of Walgreens Boots Alliance during the second quarter valued at $121,000. Finally, Cribstone Capital Management LLC bought a new position in shares of Walgreens Boots Alliance during the second quarter valued at $149,000. Institutional investors and hedge funds own 59.74% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Receive News & Stock Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related stocks with our FREE daily email newsletter.